PhRMA says California pay-for-delay law should be struck down
MLex Summary: The Pharmaceutical Research and Manufacturers of America filed a brief in support of a US appeal court ruling against California’s pay-for-delay law. It argues that AB 824 directly conflicts...To view the full article, register now.
Already a subscriber? Click here to view full article